BBIO
Price:
$66.27
Market Cap:
$12.98B
BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable candidates within its development pipeline include: AG10 and BBP-265: A small molecule designed to stabilize transthyretin (TTR), currently in a pivotal Phase 3 clinical trial targeting transthyretin amyloidosis-cardiomyopathy (ATTR-CM). BBP-831: A selective small molecule inhibitor of FGFR1-3, which is undergoing Phase 2 clinical evaluation for treating ...[Read more]
Industry
Biotechnology
IPO Date
2019-06-27
Stock Exchange
NASDAQ
Ticker
BBIO
According to BridgeBio Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 36.00%. This represents a change of 296.05% compared to the average of 9.09% of the last 4 quarters.
The mean historical ROE of BridgeBio Pharma, Inc. over the last ten years is -53.80%. The current 36.00% ROE has changed -166.91% with respect to the historical average. Over the past ten years (40 quarters), BBIO's ROE was at its highest in in the March 2021 quarter at 41.26%. The ROE was at its lowest in in the December 2020 quarter at -207.20%.
Average
-53.80%
Median
38.35%
Minimum
-774.92%
Maximum
79.73%
Discovering the peaks and valleys of BridgeBio Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.12%
Maximum Annual ROE = 79.73%
Minimum Annual Increase = -179.97%
Minimum Annual ROE = -774.92%
| Year | ROE | Change |
|---|---|---|
| 2025 | 35.12% | -3.78% |
| 2024 | 36.50% | -23.15% |
| 2023 | 47.49% | 23.84% |
| 2022 | 38.35% | -40.66% |
| 2021 | 64.63% | -108.34% |
| 2020 | -774.92% | 1.12% |
| 2019 | -63.76% | -179.97% |
| 2018 | 79.73% | 51.34% |
The current ROE of BridgeBio Pharma, Inc. (BBIO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
39.70%
5-year avg
44.42%
10-year avg
-53.80%
BridgeBio Pharma, Inc.’s ROE is greater than Revolution Medicines, Inc. (-83.22%), greater than Ionis Pharmaceuticals, Inc. (-58.57%), greater than Ascendis Pharma A/S (-5641.90%), greater than Summit Therapeutics Inc. (-340.55%), greater than Roivant Sciences Ltd. (-6.85%), greater than Moderna, Inc. (-36.73%), less than BioMarin Pharmaceutical Inc. (4.41%), less than Exelixis, Inc. (40.21%), greater than Atrium Therapeutics, Inc. (-29.67%), less than Jazz Pharmaceuticals plc (0.71%),
| Company | ROE | Market cap |
|---|---|---|
| -83.22% | $34.65B | |
| -58.57% | $12.25B | |
| -5641.90% | $14.34B | |
| -340.55% | $10.67B | |
| -6.85% | $22.61B | |
| -36.73% | $25.38B | |
| 4.41% | $10.57B | |
| 40.21% | $13.05B | |
| -29.67% | $216.56M | |
| 0.71% | $14.11B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BridgeBio Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BridgeBio Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BridgeBio Pharma, Inc.'s ROE?
How is the ROE calculated for BridgeBio Pharma, Inc. (BBIO)?
What is the highest ROE for BridgeBio Pharma, Inc. (BBIO)?
What is the 3-year average ROE for BridgeBio Pharma, Inc. (BBIO)?
What is the 5-year average ROE for BridgeBio Pharma, Inc. (BBIO)?
How does the current ROE for BridgeBio Pharma, Inc. (BBIO) compare to its historical average?